Protocols›Cognitive & neuro›Calm & Sleep
← Protocols
Stress · anxiolyticResilience · daytimeRussia-registered

Stress & Resilience

Stack: Selank + Semax · the daytime, stress-facing side of the neuro category
"The daytime counterpart to Calm & Sleep. Selank takes the edge off anxiety without sedation or dependence; Semax is the stress-resilience and mental-clarity piece. Honest framing: both carry a real Russian clinical record but thin Western replication, and neither is a UK-licensed medicine."
GoalDaytime anxiety / stress resilience
Compounds2 · Selank + Semax
Human evidenceLimited–moderate — Russian clinical for both; limited Western RCTs
StatusUK: unlicensed research chemicals — not controlled, legal to possess, but not approved medicines. Russia: both registered (Selank for anxiety; Semax for cognition/stroke)
In this stack — snapshot; tap through for the full molecule file
Provenance & evidence layers — of the combination, not the parts
Registered use (Russia)
Selank
A registered anxiolytic medicine in Russia (Institute of Molecular Genetics), in clinical use for generalised anxiety since the 1990s.
Semax
Registered in Russia as a nootropic / neuroprotective medicine — used clinically for ischaemic stroke and cognitive indications.
Evidence it adds
Real-world Russian clinical exposure for both peptides.
Basis: Russian pharmacology registration (both)
Research / trial evidence
Selank
Russian RCTs describe anxiolytic and mild nootropic effects without the sedation or dependence of benzodiazepines — modest samples, limited Western replication.
Semax
Russian trials report neuroprotective and pro-cognitive effects, including in stroke recovery — again, little independent Western replication.
Evidence it adds
Moderate for both by Russian standards; thin outside Russia.
Basis: Russian clinical literature · limited Western RCTs
Grey-market / unsupervised use
Where / who
Both are sold as research peptides, usually intranasal, reconstituted from lyophilised powder.
What changes
Product identity, purity and dose are unverified; the Russian safety record belongs to the registered product, not a grey-market vial.
Evidence it adds
None — this layer is about how unsupervised use diverges from the studied product.
Basis: real-world sourcing — not a trial tier
Regulatory — read carefully
MHRA (UK)
Neither is a licensed medicine and neither is a controlled drug — unlicensed research chemicals. "Legal to possess" is not "approved or safe".
Elsewhere
Both are registered in Russia; not FDA- or EMA-approved.
What it means
Low apparent toxicity, but the strong evidence sits in Russian clinical practice, not Western trials.
Basis: MHRA: unlicensed, not scheduled
Why this pairing

Calm & Sleep covers the night — anxiety at bedtime and sleep onset. This pairing is the daytime counterpart, aimed at stress and anxiety while you’re awake and functioning. Selank is the anchor: a Russia-registered anxiolytic with a real, if modest, clinical record, used for anxiety without the sedation or dependence of benzodiazepines. Semax is its up-regulation sibling — a neuroprotective, pro-cognitive peptide studied for clarity and resilience under load. The honest framing: both carry genuine Russian clinical exposure but little Western replication, and neither is a UK-licensed medicine.

Members only · the actionable depth
See exactly how it's run
Doses, titration structure and what to monitor are part of membership. The provenance, evidence and status above are always free.
Get the tracker · £4.99/mo →
£4.99/mo · cancel anytime
Cycle shape — how it's typically structured, not a schedule to follow
Selank
intranasal, daily / as needed
Semax
intranasal, daytime
Review
cycle / reassess
Selank is typically used intranasally through the day or before stressful moments; Semax intranasally earlier in the day for clarity and stress resilience. These mirror community and Russian-clinical patterns, not a prescription to follow.
What's worth monitoring

Both peptides have a low reported toxicity profile, and Selank in particular is noted for the absence of sedation, tolerance or dependence seen with conventional anxiolytics. The real caveats are evidential and practical: the strong data lives in Russian clinical practice, Western replication is thin, and grey-market product identity and purity are unverified. Baseline sensibility and a clinician conversation are the floor. General information, not medical advice.

Evidence
Selank · anxiety Moderate

Russian clinical use for generalised anxiety — anxiolytic without sedation or dependence; limited Western replication.

Semax · stress / cognition Moderate

Russia-registered nootropic/neuroprotective; Russian trials in stroke and cognition, limited independent replication.

Unsupervised use Risk shifts

Grey-market identity and purity are unverified; the studied record belongs to the registered product.

The honest point

Both have a real Russian clinical record — but thin Western data. Evidenced in Russia, experimental here.

Fast facts
Compounds

Selank · Semax

Routes

Both intranasal

UK strip

GREEN — legal to possess (unlicensed)